Gilead Sciences Inc to ramp up production of experimental COVID-19 treatment with international partners

In a statement Gilead Sciences Inc, the maker of the closely-watched experimental coronavirus drug remdesivir stated, it will continue to work with international partners to expand the production of its potential COVID-19 treatment. Gilead said, it expects to have more than one million remdesivir treatment courses manufactured by December, “with plans to be able to…

Researchers from Peter Doherty Institute for Infection and Immunity map immune response to Wuhan coronavirus

On Tuesday, Australian researchers disclosed, they have mapped the immune responses from one of country’s first coronavirus patients in an important step that closes the gap towards developing a vaccine and treatment for the Wuhan Coronavirus. While the bulk of those infected show only mild symptoms, nearly 20% of the patients are in critical conditions.…